Literature DB >> 16002701

Critical role of the fifth domain of E-cadherin for heterophilic adhesion with alpha E beta 7, but not for homophilic adhesion.

Kiyono Shiraishi1, Kensei Tsuzaka, Keiko Yoshimoto, Chika Kumazawa, Kyoko Nozaki, Tohru Abe, Kazuo Tsubota, Tsutomu Takeuchi.   

Abstract

The integrin alpha(E)beta(7) is expressed on intestinal intraepithelial T lymphocytes and CD8(+) T lymphocytes in inflammatory lesions near epithelial cells. Adhesion between alpha(E)beta(7)(+) T and epithelial cells is mediated by the adhesive interaction of alpha(E)beta(7) and E-cadherin; this interaction plays a key role in the damage of target epithelia. To explore the structure-function relationship of the heterophilic adhesive interaction between E-cadherin and alpha(E)beta(7), we performed cell aggregation assays using L cells transfected with an extracellular domain-deletion mutant of E-cadherin. In homophilic adhesion assays, L cells transfected with wild-type or a domain 5-deficient mutant formed aggregates, whereas transfectants with domain 1-, 2-, 3-, or 4-deficient mutants did not. These results indicate that not only domain 1, but domains 2, 3, and 4 are involved in homophilic adhesion. When alpha(E)beta(7)(+) K562 cells were incubated with L cells expressing the wild type, 23% of the resulting cell aggregates consisted of alpha(E)beta(7)(+) K562 cells. In contrast, the binding of alpha(E)beta(7)(+) K562 cells to L cells expressing a domain 5-deficient mutant was significantly decreased, with alpha(E)beta(7)(+) K562 cells accounting for only 4% of the cell aggregates, while homophilic adhesion was completely preserved. These results suggest that domain 5 is involved in heterophilic adhesion with alpha(E)beta(7), but not in homophilic adhesion, leading to the hypothesis that the fifth domain of E-cadherin may play a critical role in the regulation of heterophilic adhesion to alpha(E)beta(7) and may be a potential target for treatments altering the adhesion of alpha(E)beta(7)(+) T cells to epithelial cells in inflammatory epithelial diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002701     DOI: 10.4049/jimmunol.175.2.1014

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Improving the stability of the EC1 domain of E-cadherin by thiol alkylation of the cysteine residue.

Authors:  Maulik Trivedi; Jennifer S Laurence; Todd D Williams; C Russell Middaugh; Teruna J Siahaan
Journal:  Int J Pharm       Date:  2012-04-17       Impact factor: 5.875

2.  Mapping transmembrane binding partners for E-cadherin ectodomains.

Authors:  Omer Shafraz; Bin Xie; Soichiro Yamada; Sanjeevi Sivasankar
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 11.205

3.  Co-operative roles for E-cadherin and N-cadherin during lens vesicle separation and lens epithelial cell survival.

Authors:  Giuseppe F Pontoriero; April N Smith; Leigh-Anne D Miller; Glenn L Radice; Judith A West-Mays; Richard A Lang
Journal:  Dev Biol       Date:  2008-11-01       Impact factor: 3.582

4.  Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition.

Authors:  Yvonne L Chao; Christopher R Shepard; Alan Wells
Journal:  Mol Cancer       Date:  2010-07-07       Impact factor: 27.401

5.  Evaluation of the physical stability of the EC5 domain of E-cadherin: effects of pH, temperature, ionic strength, and disulfide bonds.

Authors:  Kai Zheng; C Russell Middaugh; Teruna J Siahaan
Journal:  J Pharm Sci       Date:  2009-01       Impact factor: 3.534

6.  Characterization of multiple stable conformers of the EC5 domain of E-cadherin and the interaction of EC5 with E-cadherin peptides.

Authors:  Kai Zheng; Jennifer S Laurence; Krzysztof Kuczera; Gennady Verkhivker; C Russell Middaugh; Teruna J Siahaan
Journal:  Chem Biol Drug Des       Date:  2009-06       Impact factor: 2.817

7.  (1)H, (13)C and (15)N backbone assignment of the EC-1 domain of human E-cadherin.

Authors:  Vivitri D Prasasty; Mary E Krause; Usman S F Tambunan; Asokan Anbanandam; Jennifer S Laurence; Teruna J Siahaan
Journal:  Biomol NMR Assign       Date:  2014-02-08       Impact factor: 0.746

8.  Club Cell TRPV4 Serves as a Damage Sensor Driving Lung Allergic Inflammation.

Authors:  Darin L Wiesner; Richard M Merkhofer; Carole Ober; Gregory C Kujoth; Mengyao Niu; Nancy P Keller; James E Gern; Rebecca A Brockman-Schneider; Michael D Evans; Daniel J Jackson; Thomas Warner; Nizar N Jarjour; Stephane J Esnault; Michael B Feldman; Matthew Freeman; Hongmei Mou; Jatin M Vyas; Bruce S Klein
Journal:  Cell Host Microbe       Date:  2020-03-03       Impact factor: 31.316

9.  Stromal cells positively and negatively modulate the growth of cancer cells: stimulation via the PGE2-TNFα-IL-6 pathway and inhibition via secreted GAPDH-E-cadherin interaction.

Authors:  Manabu Kawada; Hiroyuki Inoue; Shun-ichi Ohba; Junjiro Yoshida; Tohru Masuda; Manabu Yamasaki; Ihomi Usami; Shuichi Sakamoto; Hikaru Abe; Takumi Watanabe; Takao Yamori; Masakatsu Shibasaki; Akio Nomoto
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

10.  Minus end-directed motor KIFC3 suppresses E-cadherin degradation by recruiting USP47 to adherens junctions.

Authors:  Kyoko Sako-Kubota; Nobutoshi Tanaka; Shigenori Nagae; Wenxiang Meng; Masatoshi Takeichi
Journal:  Mol Biol Cell       Date:  2014-09-24       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.